Harries, Anthony D <br/><br/>
Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.  [electronic resource] 

 -  The Lancet. Infectious diseases  Dec 2015 
 - 1492-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(15)00242-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Africa South of the Sahara<br/>Anti-HIV Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>Antitubercular Agents--therapeutic use<br/>Coinfection<br/>Drug Combinations<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Isoniazid--therapeutic use<br/>Male<br/>Mycobacterium tuberculosis--drug effects<br/>Tablets<br/>Time Factors<br/>Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use<br/>Tuberculosis, Pulmonary--microbiology<br/>Vitamin B 6--therapeutic use